vs
Cronos Group Inc.（CRON）与IM Cannabis Corp.（IMCC）财务数据对比。点击上方公司名可切换其他公司
Cronos Group Inc.的季度营收约是IM Cannabis Corp.的4394.0倍（$44.5M vs $10.1K）。Cronos Group Inc.净利率更高（-4.1% vs -7.8%，领先3.7%）。Cronos Group Inc.自由现金流更多（$9.7M vs $2.2K）
Cronos集团是全球性大麻素企业，主营大麻种植、加工及相关衍生产品的分销业务，产品线覆盖健康补充剂、快消品及医用大麻品类，主要服务北美、欧洲、亚太地区的合规娱乐与医用消费市场，严格遵循各地监管要求保障产品品质。
IM Cannabis Corp是一家跨国大麻企业，专注于医用及成人娱乐用大麻的种植、生产、分销与零售业务，核心市场覆盖北美、欧盟及以色列，旗下拥有多个大麻品牌，同时销售大麻衍生健康消费品。
CRON vs IMCC — 直观对比
营收规模更大
CRON
是对方的4394.0倍
$10.1K
净利率更高
CRON
高出3.7%
-7.8%
自由现金流更多
CRON
多$9.7M
$2.2K
损益表 — Q4 2025 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $44.5M | $10.1K |
| 净利润 | $-1.8M | $-790 |
| 毛利率 | 36.4% | 22.7% |
| 营业利润率 | -16.8% | -6.9% |
| 净利率 | -4.1% | -7.8% |
| 营收同比 | 47.0% | — |
| 净利润同比 | -104.2% | — |
| 每股收益（稀释后） | $-0.01 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRONIMCC
| Q4 25 | $44.5M | — | ||
| Q3 25 | $36.3M | $10.1K | ||
| Q2 25 | $33.5M | $8.8K | ||
| Q1 25 | $32.3M | — | ||
| Q4 24 | $30.3M | $11.8K | ||
| Q3 24 | $34.3M | $9.0K | ||
| Q2 24 | $27.8M | $10.8M | ||
| Q1 24 | $25.3M | $9.1K |
净利润CRONIMCC
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $26.0M | $-790 | ||
| Q2 25 | $-39.7M | $-4.4K | ||
| Q1 25 | $6.1M | — | ||
| Q4 24 | $43.7M | — | ||
| Q3 24 | $8.3M | $-1.6K | ||
| Q2 24 | $-8.8M | $-2.5M | ||
| Q1 24 | $-2.2M | — |
毛利率CRONIMCC
| Q4 25 | 36.4% | — | ||
| Q3 25 | 50.4% | 22.7% | ||
| Q2 25 | 43.4% | 14.7% | ||
| Q1 25 | 42.6% | — | ||
| Q4 24 | 35.7% | — | ||
| Q3 24 | 10.5% | 21.4% | ||
| Q2 24 | 22.7% | 5.7% | ||
| Q1 24 | 17.7% | 23.2% |
营业利润率CRONIMCC
| Q4 25 | -16.8% | — | ||
| Q3 25 | -1.4% | -6.9% | ||
| Q2 25 | -15.9% | -46.7% | ||
| Q1 25 | -12.6% | — | ||
| Q4 24 | -37.5% | -236.7% | ||
| Q3 24 | -98.2% | 18.3% | ||
| Q2 24 | -56.1% | -19.5% | ||
| Q1 24 | -63.1% | 28.9% |
净利率CRONIMCC
| Q4 25 | -4.1% | — | ||
| Q3 25 | 71.4% | -7.8% | ||
| Q2 25 | -118.7% | -49.9% | ||
| Q1 25 | 19.0% | — | ||
| Q4 24 | 144.3% | — | ||
| Q3 24 | 24.4% | -17.3% | ||
| Q2 24 | -31.5% | -23.4% | ||
| Q1 24 | -8.9% | — |
每股收益（稀释后）CRONIMCC
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $0.07 | — | ||
| Q2 25 | $-0.10 | — | ||
| Q1 25 | $0.02 | — | ||
| Q4 24 | $0.12 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $-0.02 | — | ||
| Q1 24 | $-0.01 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $831.8M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.1B | — |
| 总资产 | $1.2B | — |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRONIMCC
| Q4 25 | $831.8M | — | ||
| Q3 25 | $824.2M | — | ||
| Q2 25 | $834.4M | — | ||
| Q1 25 | $837.8M | — | ||
| Q4 24 | $858.8M | $630.0K | ||
| Q3 24 | $862.0M | — | ||
| Q2 24 | $848.2M | $511.0K | ||
| Q1 24 | $855.1M | — |
股东权益CRONIMCC
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | $2.3M | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | $4.0M | ||
| Q1 24 | $1.1B | — |
总资产CRONIMCC
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.2B | $28.6M | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | $29.4M | ||
| Q1 24 | $1.1B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.8M | $2.3K |
| 自由现金流经营现金流 - 资本支出 | $9.7M | $2.2K |
| 自由现金流率自由现金流/营收 | 21.8% | 21.6% |
| 资本支出强度资本支出/营收 | 4.8% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $149.0K | — |
8季度趋势，按日历期对齐
经营现金流CRONIMCC
| Q4 25 | $11.8M | — | ||
| Q3 25 | $13.3M | $2.3K | ||
| Q2 25 | $2.8M | — | ||
| Q1 25 | $-2.1M | — | ||
| Q4 24 | $7.7M | $-786.2K | ||
| Q3 24 | $11.6M | — | ||
| Q2 24 | $1.7M | — | ||
| Q1 24 | $-2.2M | $-4.4K |
自由现金流CRONIMCC
| Q4 25 | $9.7M | — | ||
| Q3 25 | $8.8M | $2.2K | ||
| Q2 25 | $-1.0M | — | ||
| Q1 25 | $-17.4M | — | ||
| Q4 24 | $4.2M | — | ||
| Q3 24 | $5.2M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | $-3.9M | $-4.7K |
自由现金流率CRONIMCC
| Q4 25 | 21.8% | — | ||
| Q3 25 | 24.3% | 21.6% | ||
| Q2 25 | -3.0% | — | ||
| Q1 25 | -53.8% | — | ||
| Q4 24 | 13.8% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -15.5% | -51.7% |
资本支出强度CRONIMCC
| Q4 25 | 4.8% | — | ||
| Q3 25 | 12.3% | 0.9% | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | 47.3% | — | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 18.7% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 6.8% | 3.3% |
现金转化率CRONIMCC
| Q4 25 | — | — | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.34× | — | ||
| Q4 24 | 0.18× | — | ||
| Q3 24 | 1.39× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
IMCC
暂无分部数据
